We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

179 hedge funds and large institutions have $1.21B invested in Sarepta Therapeutics in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 44 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $108M | Put options by funds: $54.9M

45% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 44

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

11% more capital invested

Capital invested by funds: $1.08B → $1.21B (+$123M)

2.09% more ownership

Funds ownership: 72.29% → 74.38% (+2.1%)

1% more funds holding

Funds holding: 177 → 179 (+2)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
179
Holders Change
+2
Holders Change %
+1.13%
% of All Funds
4.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
39
Increased
64
Reduced
44
Closed
28
Calls
$108M
Puts
$54.9M
Net Calls
+$53.5M
Net Calls Change
+$36.4M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$160M
2
HM
HealthCor Management
New York
+$48M
3
CCM
Camber Capital Management
Massachusetts
+$41.8M
4
O
OrbiMed
New York
+$32.6M
5
PC
PointState Capital
New York
+$19.8M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$62.4M
2
PA
Perceptive Advisors
New York
-$30.9M
3
ACA
Avoro Capital Advisors
New York
-$27.7M
4
JG
Jefferies Group
New York
-$26M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
26
Pinnacle Associates
New York
$10.7M +$11.2M +361,701 New
Invesco
27
Invesco
Georgia
$10.7M -$2.96M -95,557 -21%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$10.7M -$634K -20,500 -5%
CCM
29
Cadian Capital Management
New York
$10.2M -$97.3K -3,143 -0.9%
PP
30
PDT Partners
New York
$10M +$10.5M +338,997 New
TA
31
Teachers Advisors
New York
$8.61M +$2.11M +68,207 +31%
Hudson Bay Capital Management
32
Hudson Bay Capital Management
Connecticut
$8.23M +$3.43M +110,836 +66%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$7.92M -$14.2M -458,365 -63%
Deutsche Bank
34
Deutsche Bank
Germany
$7.79M -$1.58M -51,204 -16%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$7.34M +$59.5K +1,923 +0.8%
SC
36
Samlyn Capital
New York
$6.93M +$7.25M +234,300 New
Capital Fund Management (CFM)
37
Capital Fund Management (CFM)
France
$6.6M +$6.9M +223,101 New
QF
38
QVT Financial
New York
$6.56M +$276K +8,915 +4%
Charles Schwab
39
Charles Schwab
California
$6.07M +$343K +11,079 +6%
TCIM
40
TIAA CREF Investment Management
New York
$5.92M -$410K -13,244 -6%
AG
41
Artal Group
Luxembourg
$5.92M – – –
RSCM
42
Rock Springs Capital Management
Maryland
$5.74M +$65K +2,100 +1%
Morgan Stanley
43
Morgan Stanley
New York
$5.63M -$593K -19,174 -9%
CS
44
Credit Suisse
Switzerland
$5.51M +$3.49M +112,899 +154%
JP Morgan Chase
45
JP Morgan Chase
New York
$4.78M +$3.03M +98,025 +154%
ARTA
46
A.R.T. Advisors
New York
$4.78M +$5M +161,400 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$4.09M -$186K -6,000 -4%
Millennium Management
48
Millennium Management
New York
$3.98M -$6.41M -207,036 -61%
FAM
49
Fred Alger Management
New York
$3.67M -$45.2K -1,462 -1%
Group One Trading
50
Group One Trading
Illinois
$3.63M +$3.8M +122,659 New
1
2
3 4 5

SRPT Hedge Fund Activity: Q1 2017 in Review

179 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q1 2017, worth a combined $1.21B — up 11% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SRPT positions and 28 closed out — a net gain of 11 holders — while 64 added to existing stakes and 44 trimmed.

The largest buyer was BlackRock, adding an estimated $160M. The largest seller was Sabby Management, exiting entirely with an estimated $62.4M sold.

  • 179 institutional investors held Sarepta Therapeutics (SRPT) as of Q1 2017, up from 177 in Q4 2016.
  • Funds reported $1.21B of Sarepta Therapeutics stock for Q1 2017, up 11% quarter-over-quarter.
  • 39 funds opened new Sarepta Therapeutics positions in Q1 2017 and 28 closed out, a net change of +11 holders.
  • The largest Sarepta Therapeutics buyer in Q1 2017 was BlackRock, an estimated $160M added.
  • The largest Sarepta Therapeutics seller in Q1 2017 was Sabby Management, an estimated $62.4M sold.

Based on aggregated 13F filings for Q1 2017.